Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nimvec AM510
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Amarna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Amarna and NorthX Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy
Details : Under the terms of the agreement, Amarna enables the transfer & optimization of Amarna’s research-scale production process for Nimvec AM510 to NorthX. It is being evaluated for Type 1 Diabetes.
Product Name : Nimvec AM510
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 08, 2025
Lead Product(s) : Nimvec AM510
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Amarna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement